Author Review Workspace

1) Evidence mapping — what the corpus shows

• High-impact clinical research (example — dementia): Gill Livingston is first/corresponding author of the Lancet dementia Commission (2020) — a synthesis of epidemiology, risk factors, and interventions that is highly cited and influential in guidelines and research agendas, indicating world-class translational leadership in dementia research (Lancet Commission (Livingston et al. 2020)).
• Historical/biography medical writing: David Livingstone (19th-century explorer) is the subject of medically framed historical analyses (e.g., uvulectomy review) — scholarly but historical/qualitative in nature, not primary biomedical research (Livingstone uvulectomy (J Med Biogr 2006)).

2) Critical evaluation framework I used (method)

1. Resolve author identity (disambiguate name — crucial).
2. Assess topical domain (clinical trial/commission vs narrative review vs engineering/technical report).
3. Weight evidence by: study type (RCTs/meta-analyses > observational > narrative), sample size, reproducibility indicators, transparency (data/code availability), and citation impact.
4. Check for conflicts of interest, funder influence, and potential biases (selection, publication, omission).

3) Example-specific critique (two representative 'Livingstons')

4) Common problems I found across 'Livingston' publications in the scraped corpus

• Author-name ambiguity: multiple distinct "Livingston" authors produce papers across history, clinical, ecology, and engineering domains — risk of mistaken attribution or over-generalization.
• Heterogeneous evidence quality: corpus contains high-quality systematic reviews/commissions (Lancet) and many narrative reviews, case reports, or technical notes — mix demands tailored appraisal per-paper.
• Frequent reliance on narrative review or historical methods for some Livingstons; these are valuable but should not be conflated with hypothesis-testing biomedical science.
• Transparency/reporting gaps: several entries in the scraped dataset lacked clear data availability, code, or raw-data deposition — a reproducibility limitation for quantitative biology work in general.

5) Practical recommendations for anyone reviewing a 'Livingston' manuscript

1. Resolve identity: confirm ORCID, institutional affiliation, and full name (e.g., Gill Livingston vs H. Livingston vs David Livingstone) before analyzing impact or expertise.
2. Classify manuscript type: RCT/systematic review, observational, narrative review, case report, or historical piece — apply the appropriate critical checklist (PRISMA for systematic reviews, CONSORT for RCTs, CARE for case reports, historical-source criteria for biographies).
3. Check primary evidence and heterogeneity: if conclusions rely on observational meta-analyses, inspect heterogeneity, bias assessments, and sensitivity analyses; for commissions, inspect how low-quality primary studies influence recommendations.
4. Demand transparency: raw data, analysis code, and methods details increase trustworthiness; absent these, downgrade certainty and highlight reproducibility limitations.

6) Quick decision guide (one-line rules)

• If the target 'Livingston' is Gill (dementia): treat as high-impact clinical-policy research — evaluate primary- evidence heterogeneity and applicability to subgroups.
• If the target is a historical/biographical 'Livingstone' (David Livingstone): value for historical context, not for modern biological claims.
• If the target is an engineering/technical Livingston with low citation metrics (author H. Livingston in scraped metadata): expect applied/technical domain work; verify domain expertise and reproducibility standards.

Citations used in this author-review (representative)

1. Lancet Commission (Livingston et al. 2020)
2. Livingstone uvulectomy (J Med Biogr 2006)
3. Subclinical Hypothyroidism (JAMA 2019)

Final targeted advice — what I would do next (actionable)

If you give me the exact Livingston (full given name, ORCID or a key paper), I will: (1) fetch the author’s OpenAlex/Scopus profile, (2) assemble their top 10 papers, (3) run a quick evidence-quality matrix (study types, sample sizes, reproducibility flags), and (4) produce an itemized, defensible critique and suggested edits to strengthen their next manuscript. Click the button to run that agent.